1. Home
  2. TRVI vs RRBI Comparison

TRVI vs RRBI Comparison

Compare TRVI & RRBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVI
  • RRBI
  • Stock Information
  • Founded
  • TRVI 2011
  • RRBI 1998
  • Country
  • TRVI United States
  • RRBI United States
  • Employees
  • TRVI N/A
  • RRBI N/A
  • Industry
  • TRVI Biotechnology: Pharmaceutical Preparations
  • RRBI Hotels/Resorts
  • Sector
  • TRVI Health Care
  • RRBI Consumer Discretionary
  • Exchange
  • TRVI Nasdaq
  • RRBI Nasdaq
  • Market Cap
  • TRVI 341.4M
  • RRBI 357.4M
  • IPO Year
  • TRVI 2019
  • RRBI 2019
  • Fundamental
  • Price
  • TRVI $4.24
  • RRBI $56.19
  • Analyst Decision
  • TRVI Strong Buy
  • RRBI
  • Analyst Count
  • TRVI 8
  • RRBI 0
  • Target Price
  • TRVI $9.31
  • RRBI N/A
  • AVG Volume (30 Days)
  • TRVI 454.6K
  • RRBI 16.2K
  • Earning Date
  • TRVI 03-19-2025
  • RRBI 01-30-2025
  • Dividend Yield
  • TRVI N/A
  • RRBI 0.65%
  • EPS Growth
  • TRVI N/A
  • RRBI 1.85
  • EPS
  • TRVI N/A
  • RRBI 4.95
  • Revenue
  • TRVI N/A
  • RRBI $108,535,000.00
  • Revenue This Year
  • TRVI N/A
  • RRBI N/A
  • Revenue Next Year
  • TRVI N/A
  • RRBI $5.60
  • P/E Ratio
  • TRVI N/A
  • RRBI $11.21
  • Revenue Growth
  • TRVI N/A
  • RRBI 1.61
  • 52 Week Low
  • TRVI $1.39
  • RRBI $42.78
  • 52 Week High
  • TRVI $4.68
  • RRBI $62.13
  • Technical
  • Relative Strength Index (RSI)
  • TRVI 60.00
  • RRBI 58.33
  • Support Level
  • TRVI $3.81
  • RRBI $54.15
  • Resistance Level
  • TRVI $4.04
  • RRBI $56.20
  • Average True Range (ATR)
  • TRVI 0.25
  • RRBI 1.41
  • MACD
  • TRVI -0.00
  • RRBI 0.61
  • Stochastic Oscillator
  • TRVI 90.89
  • RRBI 89.29

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About RRBI Red River Bancshares Inc.

Red River Bancshares Inc is the bank holding company for the red river bank. The principal business of the Bank is lending and accepting deposits from businesses, professionals, individuals, and public entities. The bank's primary deposit products are demand deposits, savings deposits, and time deposits. The bank maintains a diversified loan portfolio with a focus on commercial real estate (Owner Occupied and Non-Owner Occupied), one-to-four-family residential, commercial, and industrial loans, construction and development Loans, and others. also, provides Treasury Management Services, Private Banking Services, Brokerage Services, and Other Banking Services.

Share on Social Networks: